Michael Moynihan (Cork North West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

296. To ask the Minister for Health to investigate the possibility of including the medication Frampya for the treatment of multiple sclerosis on the medical card and long-term illness schemes; the reason this is not already included in such schemes; when a decision will be made on this; and if he will make a statement on the matter. [7411/16]

Kathleen Lynch (Cork North Central, Labour)
Link to this: Individually | In context | Oireachtas source

Fampridine (brand name Fampyra) has been reimbursed under the Long Term Illness Scheme on a conditional, responder-only basis since 1 October 2015.

The HSE has provided all Neurology Centres with details of the protocol which must be satisfied to enable a patient to qualify for reimbursement.

Reimbursement will be extended where a demonstration of clinical response (based on objective criteria agreed with clinical experts) is recorded and where that clinical response is shown to persist, based on objective measurement at six-monthly intervals. The HSE extends reimbursement in all cases where the criteria meet the requirements of reimbursement protocol.